The Desensitization Therapy With GB-0998 for Anti-donor Antibody-positive Recipients.
Phase of Trial: Phase II/III
Latest Information Update: 12 Feb 2016
Price : $35 *
At a glance
- Drugs Immunoglobulin G (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 04 Feb 2016 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 11 Feb 2014 New trial record